They demonstrated that knockdown of Brd4 and Myc inhibited growth in Notch1-positive mouse T-ALL cell lines, and JQ1 treatment showed a significant dose-dependent decrease in cellular growth along with reduction in MYC protein expression in a panel of T-ALL cell lines and in primary human T-ALL samples tested in vitro. This evidence concerns the gene BRD4 and acute lymphoblastic leukemia.